/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
SASKATOON, SK, July 29, 2025 /CNW/ - ZYUS Life Sciences Corporation (the "Company") (TSXV: ZYUS), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, is pleased to announce that it has now completed a first tranche (the "First Tranche") of its non-brokered private placement (the "Offering") of up to 1,408,450 units (each a "Unit") for up to CAD $1,000,000. Under the First Tranche of the Offering, 450,281 Units were issued at a price of $0.71 per Unit for gross proceeds of approximately $319,700.
Read more at newswire.ca